Company / Inventory
Aurinia Pharmaceuticals Inc. Inventory History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$45.7M
FY2025
5-year range
$19.3M / $45.7M
FY2021-FY2025
Trend
+16.5%
vs FY2024
Sector context
#58 of 105
Health Care
What the data says
At $46M, Aurinia Pharmaceuticals Inc.'s inventory ranks #58 of 105 in the Health Care sector. Improved from $40M to $46M over the past 2 years.
Based on SEC 10-K filings.
$46M in FY2025 with a 5-year CAGR of +26.8%.
Improved from $40M to $46M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +22.7%
- 5-Year CAGR
- +26.8%
- 10-Year CAGR
- -
Sector benchmark
#58 of 105 in Health CareTop 55% of 105This company $45.7M Sector average $885.3M
▼
-94.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.8%, indicating consistent growth.
- In FY2025, inventory increased 16.5% year-over-year.
- Ranks #58 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.7M | +16.5% |
| FY2024 | $39.2M | -1.2% |
| FY2023 | $39.7M | +60.4% |
| FY2022 | $24.8M | +28.1% |
| FY2021 | $19.3M | +38.8% |
| FY2020 | $13.9M | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026